Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-10

Clinical Trial Update: The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating N-acetylcysteine vs placebo for methamphetamine withdrawal symptoms; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Melva Louisa | Conditions: Methamphetamine Dependence in Remission | Phase 2, Phase 3 | Status: COMPLETED